サンプル依頼リスト カート
  • English
  • Korean
表紙：冷痛療法の世界市場-2023年～2030年
市場調査レポート
商品コード
1297796

冷痛療法の世界市場-2023年～2030年

Global Cold Pain Therapy Market - 2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 195 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
冷痛療法の世界市場-2023年～2030年
出版日: 2023年06月15日
発行: DataM Intelligence
ページ情報: 英文 195 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場概要

世界の冷痛療法市場は、2022年に18億米ドルに達し、2030年には28億米ドルに達するという有利な成長が予測されています。世界の冷痛療法市場は、予測期間2023-2030年にCAGR 5.9%を示すと予測されています。

冷温療法は、手術後の痛みや腫れを軽減するために頻繁に使用されます。術後のリハビリを改善することで、膝関節置換術や人工股関節置換術などの関節手術の治癒を早めることができます。

市場力学

外傷や整形外科的損傷の増加が、予測期間中の世界の冷痛療法市場の成長を後押ししています

ヘルスケアシステムは、世界の外傷による深刻かつ増大する課題に直面しています。世界保健機関（WHO）によると、外傷の90％は低・中所得国で発生していると考えられており、外傷は世界の主要な死因の1つとなっています。

整形外科的損傷は、重傷のかなりの部分を占めています。整形外科的損傷は、骨、靭帯、関節、腱、筋肉、神経からなる筋骨格系に害を及ぼします。

積極的な主要プレーヤーが世界の冷痛療法市場の成長機会を提供します

2022年1月、ReckittブランドのBiofreezeとの複数年契約がRock'n'Roll Running Seriesから発表されました。この新たな提携により、バイオフリーズは同シリーズおよび米国で開催されるすべてのロックンロール・ランニング・シリーズの公式外部疼痛緩和パートナーとして、フィニッシュライン・フェスティバルやレースコースで参加者や観客に疼痛緩和を提供します。バイオフリーズは、腰痛、関節炎、ひずみ、捻挫などによる筋肉や関節の痛みを和らげる、医師の承認を受けたコールドセラピー製品です。ロールオン、ジェル、スプレー、クリーム、パッチ、ストリップ、ペンなど、さまざまな形で販売されています。

COVID-19の影響分析

COVID-19の流行は、冷痛療法市場に大きな影響を与えました。ヘルスケアシステムと資源はCOVID-19流行の抑制と対策に注意を向けています。一部の選択的手術や緊急性のない疼痛管理は、延期または延期された必要性のない医療処置や治療のひとつです。このことは、特定の医療状況における冷痛治療の人気に影響を与えたかもしれないです。

ロシア・ウクライナ紛争分析

ロシア・ウクライナ紛争が冷痛療法市場に与える影響は複雑かつ多面的です。紛争中、人々はしばしば自宅から避難し、他の場所に安全を求めることを余儀なくされます。避難を余儀なくされた人々も、紛争の影響を受けた地域に住む人々も、冷痛療法を含む医療へのアクセスやケアの継続性に支障をきたす可能性があります。

目次

第1章 調査手法と範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響を与える要因
    • 促進要因
      • 交通事故やスポーツ別怪我の増加
    • 抑制要因
      • 冷痛療法に関する認識の欠如
    • 機会
      • 整形外科疾患の有病率の増加
    • 影響分析

第5章 業界分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • アンメットニーズ
  • 規制分析

第6章 COVID-19の分析

第7章 ロシアとウクライナの戦争分析

第8章 人工知能分析

第9章 製品別

  • OTC製品
    • クリーム
    • ジェル
    • パッチ
    • その他のOTC製品
  • 処方箋製品
    • 医薬品
    • 医療機器

第10章 アプリケーション別

  • スポーツ医学
  • 術後療法
  • 外傷と整形外科
  • その他の用途

第11章 流通チャネル別

  • 小売薬局
  • 病院薬局
  • eコマース

第12章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東とアフリカ

第13章 競合情勢

  • 競合シナリオ
  • 製品のベンチマーク
  • 企業シェア分析
  • 主な発展と戦略

第14章 企業プロファイル

  • Breg Inc.
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • Brownmed Inc.
  • Cardinal Health Inc.
  • DJO Global Inc.
  • Ossur hf
  • Performance Health
  • Medline Industries Inc.
  • IceWraps
  • Compass Health
  • Hisamitsu Pharmaceutical Co. Inc.

第15章 付録

目次
Product Code: PH3896

Market Overview

The Global Cold Pain Therapy Market reached US$ 1.8 billion in 2022 and is projected to witness lucrative growth by reaching US$ 2.8 billion by 2030. The Global Cold Pain Therapy Market is expected to exhibit a CAGR of 5.9% during the forecast period 2023-2030.

Cold therapy is frequently used to reduce pain and swelling after surgery. Improved postoperative rehabilitation can benefit joint procedures like knee or hip replacements to speed up healing.

Market Dynamics

The growing trauma and orthopedic injuries are boosting the growth of the Global Cold Pain Therapy Market during the forecast period.

Healthcare systems face a serious and growing challenge due to global traumatic injuries. According to the World Health Organisation (WHO), 90% of injuries are thought to happen in low- and middle-income countries, making traumatic injuries one of the leading causes of death worldwide.

Orthopedic injuries make up a significant portion of severe injuries. Orthopedic injuries harm the musculoskeletal system, which consists of the bones, ligaments, joints, tendons, muscles, and nerves.

Active key players provide global cold pain therapy market growth opportunities.

In January 2022, a multi-year agreement with Biofreeze, a Reckitt brand, was announced by the Rock 'n' Roll Running Series. By the new partnership, Biofreeze will serve as the Official External Pain Relief Partner of the Series and of all Rock 'n' Roll Running Series events in the United States, offering pain relief to participants and spectators at the Finish Line Festival and on the race course. Biofreeze, a cold therapy product approved by doctors, relieves aching muscles and joints brought on by backaches, arthritis, strains, and sprains. It is available in many forms, such as roll-on, gel, spray, cream, patch, strip, and pen.

COVID-19 Impact Analysis

The COVID-19 pandemic has significantly impacted the cold pain therapy market. Healthcare systems and resources have redirected their attention to containing and combating the COVID-19 epidemic. Certain elective surgeries and non-urgent pain management measures were among the non-essential medical procedures and treatments that were delayed or postponed. This might have affected cold pain treatment's popularity in specific medical contexts.

Russia-Ukraine Conflict Analysis

The impact of the Russia-Ukraine war on the cold pain therapy market is complex and multifaceted. People are frequently compelled to evacuate their homes and seek safety elsewhere during conflict. Both those who are displaced and those who live in conflict-affected areas may experience disruptions in their access to medical care and continuity of care, including cold pain therapy.

Segment Analysis

The Global Cold Pain Therapy Market is segmented based on product, application, distribution channel, and region.

The trauma and orthopedic segment is expected to dominate the market over the forecast period.

The trauma and orthopedic segment accounted for the highest market stake, accounting for approximately 37.8% of the cold pain therapy market in 2022. Orthopedic injuries are frequently managed with hard pain treatment. It can aid in lowering the discomfort, bruising, and inflammation brought on by certain orthopedic problems.

Cold pain treatment is frequently used in the early phases of sprains and strains, which are typical orthopedic ailments. Ice or cold packs applied to the affected area aid in relieving pain, edema, and inflammation.

To relieve pain and minimize swelling, cold pain therapy can be part of the first fracture treatment. It is frequently used before immobilization or surgery to manage pain and reduce tissue damage.

Geographical Analysis

Increasing collaborations and partnerships among the key players and advancement in cold pain therapy dominate the North American region.

North America is expected to dominate the Cold Pain Therapy market, accounting for around 39.3%. The United States (U.S.) Report Card for 2022 is the fourth thorough analysis of children and youth physical activity in the United States.

North America has a strong sports culture with a high degree of engagement in numerous sports and physical activities. Sports-related injuries are common as a result. In sports medicine, cold pain therapy-such as ice packs and cold compression devices is frequently used to lessen the pain, swelling, and inflammation brought on by recent injuries.

Competitive Landscape

The major global players in the market include: Breg Inc., Brownmed Inc., Cardinal Health Inc., DJO Global Inc., Ossur hf, Performance Health, Medline Industries Inc., IceWraps, Compass Health and Hisamitsu Pharmaceutical Co.

Why Purchase the Report?

  • To visualize the Global Cold Pain Therapy Market segmentation based on the product, application, distribution channel, and region and understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous cold pain therapy market-level data points with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The Global Cold Pain Therapy Market Report Would Provide Approximately 61 Tables, 57 Figures And 195 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product
  • 3.2. Snippet by Application
  • 3.3. Snippet by Distribution Channel
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing number of road accidents and sports-related injuries
    • 4.1.2. Restraints
      • 4.1.2.1. Lack of awareness regarding cold pain therapy
    • 4.1.3. Opportunity
      • 4.1.3.1. The rising prevalence of orthopedic diseases
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Unmet Needs
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. Russia-Ukraine War Analysis

8. Artificial Intelligence Analysis

9. By Product

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 9.1.2. Market Attractiveness Index, By Product
  • 9.2. OTC Products*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 9.2.3. Creams
    • 9.2.4. Gels
    • 9.2.5. Patches
    • 9.2.6. Other OTC Products
  • 9.3. Prescription Products
    • 9.3.1. Pharmaceuticals
    • 9.3.2. Medical Devices

10. By Application

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 10.1.2. Market Attractiveness Index, By Material
  • 10.2. Sports Medicine*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Post-operative Therapies
  • 10.4. Trauma and Orthopaedic
  • 10.5. Other Applications

11. By Distribution Channel

    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.1.2. Market Attractiveness Index, By Distribution Channel
  • 11.2. Retail Pharmacies*
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3. Hospital Pharmacies
  • 11.4. E-commerce

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.2.6.1. The U.S.
      • 12.2.6.2. Canada
      • 12.2.6.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.3.6.1. Germany
      • 12.3.6.2. The U.K.
      • 12.3.6.3. France
      • 12.3.6.4. Italy
      • 12.3.6.5. Spain
      • 12.3.6.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.4.6.1. Brazil
      • 12.4.6.2. Argentina
      • 12.4.6.3. Rest of South America
  • 12.5. Asia-Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.5.6.1. China
      • 12.5.6.2. India
      • 12.5.6.3. Japan
      • 12.5.6.4. Australia
      • 12.5.6.5. Rest of Asia-Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

13. Competitive Landscape

  • 13.1. Competitive Scenario
  • 13.2. Product Benchmarking
  • 13.3. Company Share Analysis
  • 13.4. Key Developments and Strategies

14. Company Profiles

  • 14.1. Breg Inc.*
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio and Description
    • 14.1.3. Financial Overview
    • 14.1.4. Key Developments
  • 14.2. Brownmed Inc.
  • 14.3. Cardinal Health Inc.
  • 14.4. DJO Global Inc.
  • 14.5. Ossur hf
  • 14.6. Performance Health
  • 14.7. Medline Industries Inc.
  • 14.8. IceWraps
  • 14.9. Compass Health
  • 14.10. Hisamitsu Pharmaceutical Co. Inc.

LIST NOT EXHAUSTIVE

15. Appendix

  • 15.1. About Us and Services
  • 15.2. Contact Us